Peptides DB

Research-centric peptide and protocol reference hub

BPC-157 vs Selank

Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team

BPC-157: Research use — not FDA-approvedSelank: Research use — not FDA-approved

A data-driven comparison of BPC-157 and Selank (also searched as Selank vs BPC-157) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

BPC-157 centers on healing, while Selank leans toward neuro. On indexed research, BPC-157 is ahead (BPC-157: 6 studies, Human evidence; Selank: 4, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • BPC-157 is strongest for healing; Selank for neuro.
  • Evidence: BPC-157 Human evidence (6 studies) vs Selank Human evidence (4).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

HealingMuscleMetabolicNeuroSleepInflammationSkin
BPC-157Selank

At a glance

BPC-157Human evidence

Body Protection Compound-157 | Pentadecapeptide

Strongest: HealingStudies: 6Level: Extensively Studied
SelankHuman evidence

Anxiolytic & Nootropic Peptide | Tuftsin Analog

Strongest: NeuroStudies: 4Level: Well Studied

BPC-157 vs Selank: side-by-side

MetricBPC-157Selank
ClassHealingCognitive
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed64
Research levelExtensively StudiedWell Studied
Strongest effectHealing & recoveryNeuro & mood
Healing & recovery4.31.0
Muscle & body comp3.30.0
Metabolic & appetite2.30.0
Neuro & mood3.04.0
Sleep & circadian0.72.0
Inflammation & immune4.01.0
Skin & aesthetics2.00.0

▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).

Mechanism & pharmacokinetics

PropertyBPC-157Selank
MechanismBody-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signalingAnxiolytic heptapeptide (Tuftsin analog)
RouteSubcutaneous / oral (research use)Intranasal / subcutaneous (research use)

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is BPC-157?

Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.

Full BPC-157 profile, mechanism & studies →

What is Selank?

### Selank Summary Selank is a synthetic peptide derived from the naturally occurring peptide tuftsin, primarily studied for its potential anxiolytic and cognitive-enhancing properties. Research into Selank has focused on its effects on neuroprotection, stress response, and cognitive function, although further studies are needed to fully understand its mechanisms and therapeutic applications.

Full Selank profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingBPC-1574.3/5 effect signal
MuscleBPC-1573.3/5 effect signal
MetabolicBPC-1572.3/5 effect signal
NeuroSelank4.0/5 effect signal
SleepSelank2.0/5 effect signal
InflammationBPC-1574.0/5 effect signal
SkinBPC-1572.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack BPC-157 and Selank?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

BPC-157 vs Selank: side effects

BPC-157
  • improved healing28
  • flushing14
  • vivid dreams11
  • nausea3
  • anxiety2
Selank

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

BPC-157 has 6 approved studies indexed (Human evidence), and Selank has 4 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is BPC-157 or Selank better?

It depends on your goal. BPC-157 is strongest for healing; Selank for neuro. BPC-157 has more indexed studies (6). See the goal-by-goal breakdown above.

Is BPC-157 or Selank better for weight loss?

BPC-157 shows the stronger metabolic & appetite profile (2.3/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.

Is BPC-157 or Selank better for muscle?

BPC-157 leads on the muscle & body-composition axis (3.3/5).

Which has more research, BPC-157 or Selank?

BPC-157 has 6 approved studies indexed (Human evidence); Selank has 4 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack BPC-157 and Selank?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of BPC-157 vs Selank?

BPC-157: community-reported improved healing, flushing, vivid dreams. Selank: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is BPC-157 or Selank FDA-approved?

BPC-157 is a research-use compound and is not FDA-approved. Selank is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Selank better than BPC-157?

For neuro, Selank has the edge; for healing, BPC-157 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

BPC-157 and Selank are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.